Programmable Delivery of Immune Adjuvant to Tumor-Infiltrating Dendritic Cells for Cancer Immunotherapy.

Liu, Jing; Li, Hong-Jun; Luo, Ying-Li; Chen, Yi-Fang; Fan, Ya-Nan; Du, Jin-Zhi; Wang, Jun

Liu, Jing; Li, Hong-Jun; Luo, Ying-Li; Chen, Yi-Fang; Fan, Ya-Nan; Du, Jin-Zhi; Wang, Jun.

Afiliação

Liu J; Guangzhou First People's Hospital, School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 510006, P. R. China.
Li HJ; School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, P. R. China.
Luo YL; Institutes for Life Sciences, School of Medicine, South China University of Technology, Guangzhou 510006, P. R. China.
Chen YF; Institutes for Life Sciences, School of Medicine, South China University of Technology, Guangzhou 510006, P. R. China.
Fan YN; Institutes for Life Sciences, School of Medicine, South China University of Technology, Guangzhou 510006, P. R. China.
Du JZ; Guangzhou First People's Hospital, School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 510006, P. R. China.
Wang J; Institutes for Life Sciences, School of Medicine, South China University of Technology, Guangzhou 510006, P. R. China.

Nano Lett ; 20(7): 4882-4889, 2020 07 08.

Article em En | MEDLINE | ID: mdl-32551705

Assuntos

Imunoterapia; Neoplasias; Adjuvantes Imunológicos; Células Dendríticas; Guanina; Humanos; Neoplasias/terapia

Palavras-chave

cancer immunotherapy; cytosine-guanine; dendritic cell; nanoadjuvant; tumor microenvironment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Limite: Humans Idioma: En Revista: Nano Lett Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google